ARDT ARDENT HEALTH INC revenue, earnings and financials
For the quarter ended June 30, 2026, ARDENT HEALTH INC reported revenue of $1.62B (down 1.4% from a year earlier), net income of $16.9M and diluted EPS of $0.12; over the last four quarters revenue was $6.41B and net income $78.2M; for the fiscal year ended December 2025 revenue was $6.32B, up 6.0% on the year before.
ARDT annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $6.32B, gross profit n/a, operating income n/a, net income $136M (margin 2.1%), EPS $0.96
- Fiscal year ended Dec 2024: revenue $5.97B, gross profit n/a, operating income n/a, net income $210M (margin 3.5%), EPS $1.58
- Fiscal year ended Dec 2023: revenue $5.41B, gross profit n/a, operating income n/a, net income $53.9M (margin 1.0%), EPS $0.43
- Fiscal year ended Dec 2022: revenue $5.13B, gross profit n/a, operating income n/a, net income $189M (margin 3.7%), EPS $1.50
ARDT quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $1.62B (down 1.4% year over year), net income $16.9M, EPS $0.12
- Quarter ended Mar 31, 2026: revenue $1.60B (up 7.0% year over year), net income $39.9M, EPS $0.28
- Quarter ended Dec 31, 2025 (from the annual report): revenue $1.61B (down 0.1% year over year), net income $45.0M, EPS $0.32
- Quarter ended Sep 30, 2025: revenue $1.58B (up 8.8% year over year), net income −$23.5M, EPS −$0.17
- Quarter ended Jun 30, 2025: revenue $1.65B (up 11.9% year over year), net income $73.0M, EPS $0.52
- Quarter ended Mar 31, 2025: revenue $1.50B (up 4.0% year over year), net income $41.4M, EPS $0.29
- Quarter ended Dec 31, 2024 (from the annual report): revenue $1.61B, net income $114M, EPS $0.84
- Quarter ended Sep 30, 2024: revenue $1.45B (up 5.2% year over year), net income $26.3M, EPS $0.19
- Quarter ended Jun 30, 2024: revenue $1.47B (up 7.5% year over year), net income $42.8M, EPS $0.34
- Quarter ended Mar 31, 2024: revenue $1.44B, net income $27.0M, EPS $0.21
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$4.15M, EPS n/a
- Quarter ended Sep 30, 2023: revenue $1.38B, net income $20.8M, EPS $0.17
- Quarter ended Jun 30, 2023: revenue $1.37B, net income $33.1M, EPS $0.26
- Quarter ended Mar 31, 2023: revenue n/a, net income $4.14M, EPS n/a
ARDT cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $471M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow $315M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow $222M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$38.4M, share buybacks n/a
ARDT balance sheet
- Jun 30, 2026: cash $724M, total assets $5.28B, total liabilities $3.54B, shareholders' equity $1.35B, long-term debt $1.07B
- Mar 31, 2026: cash $610M, total assets $5.25B, total liabilities $3.52B, shareholders' equity $1.34B, long-term debt $1.07B
- Dec 31, 2025: cash $710M, total assets $5.29B, total liabilities $3.61B, shareholders' equity $1.29B, long-term debt $1.08B
- Sep 30, 2025: cash $609M, total assets $5.15B, total liabilities $3.52B, shareholders' equity $1.24B, long-term debt $1.09B
- Jun 30, 2025: cash $541M, total assets $5.03B, total liabilities $3.38B, shareholders' equity $1.25B, long-term debt $1.09B
- Mar 31, 2025: cash $495M, total assets $4.91B, total liabilities $3.35B, shareholders' equity $1.18B, long-term debt $1.09B
- Dec 31, 2024: cash $557M, total assets $4.96B, total liabilities $3.43B, shareholders' equity $1.13B, long-term debt $1.09B
- Sep 30, 2024: cash $563M, total assets $4.80B, total liabilities $3.41B, shareholders' equity $1.01B, long-term debt $1.08B
What is ARDT's revenue?
ARDENT HEALTH INC reported $6.41B of revenue over its last four quarters, through June 30, 2026.
Is ARDT profitable?
Yes. ARDENT HEALTH INC earned $78.2M over the last four quarters.
What is ARDT's EPS?
Diluted earnings per share over the last four quarters were $0.55; $0.12 in the latest quarter.